Ieq Capital LLC Takes $23.49 Million Position in Agilent Technologies, Inc. $A

Ieq Capital LLC bought a new position in Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 176,837 shares of the medical research company’s stock, valued at approximately $23,489,000. Ieq Capital LLC owned approximately 0.06% of Agilent Technologies at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. State Street Corp lifted its position in shares of Agilent Technologies by 1.9% during the 4th quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock valued at $1,725,611,000 after acquiring an additional 241,029 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Agilent Technologies by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock worth $1,006,519,000 after purchasing an additional 25,139 shares during the period. Deutsche Bank AG lifted its holdings in shares of Agilent Technologies by 17.1% during the second quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock valued at $930,957,000 after purchasing an additional 1,024,516 shares during the last quarter. Bank of New York Mellon Corp boosted its position in shares of Agilent Technologies by 87.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after purchasing an additional 2,440,360 shares during the period. Finally, Morgan Stanley boosted its position in shares of Agilent Technologies by 15.9% in the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock valued at $686,049,000 after purchasing an additional 692,202 shares during the period.

Agilent Technologies Trading Up 1.9%

NYSE:A opened at $159.25 on Friday. The company has a market capitalization of $44.98 billion, a P/E ratio of 31.98, a P/E/G ratio of 2.77 and a beta of 1.25. The stock’s 50 day moving average price is $137.57 and its 200 day moving average price is $126.23. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.51.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the previous year, the company earned $1.31 earnings per share. The company’s revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts forecast that Agilent Technologies, Inc. will post 6.03 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A has been the subject of a number of analyst reports. Royal Bank Of Canada initiated coverage on shares of Agilent Technologies in a research note on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price objective for the company. Jefferies Financial Group initiated coverage on shares of Agilent Technologies in a report on Thursday, July 9th. They set a “hold” rating and a $135.00 price target on the stock. Morgan Stanley upped their price target on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Wells Fargo & Company lowered their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research report on Thursday, May 28th. Finally, Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and cut their target price for the company from $150.00 to $145.00 in a research note on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $160.24.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.